Spikevax dispersion for injection COVID-19 mRNA Vaccine (nucleoside modified)*

Company

Moderna Biotech Spain, S.L.

Active Ingredient

• CX-024414 (single-stranded, 5’-capped messenger RNA (mRNA) produced using a cell-free in vitro transcription from the corresponding DNA templates, encoding the viral spike (S) protein of SARS-CoV-2)

Dosage Form

–

Legal Category

A - prescription, may not be renewed

*further information is available on request to the holder of the authorisation or in the SPC